Formes cristallines du N-[2-(diéthylamino)éthyl] -5-[(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidène)méthyl] -2,4-diméthyl-1H-pyrrol-3-carboxamide et procédés pour leur préparation
- 专利权人:
- Ratiopharm GmbH
- 发明人:
- 申请号：
- EP13158832.9
- 公开号：
- EP2604603A1
- 申请日:
- 2009.03.05
- 申请国别(地区):
- EP
- 年份:
- 2013
- 代理人:
- 摘要：
- The present invention relates to novel crystal forms of Sunitinib and methods for their preparation.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- CRYSTAL FORMS OF N-[2-(DIETHYLAMINO)ETHYL]-5-[(5-FLUORO-1,2-DIHYDRO-2-OXO-3H-INDOL-3-YLIDENE)METHYL]-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXAMIDE AND METHODS FOR THEIR PREPARATION
- Kristalne oblike N-(2-(dietilamino)etil)-5-(5-fluoro-1,2-dihidro-2-okso-3H-indol-3-iliden metil)-2,4-dimetil-1H-pirol-3-karboksamida in postopki za njihovo pripravo
- IMPROVED PROCESS FOR THE PREPARATION OF HIGH PURITY SUNITINIB AND ITS PHARMACEUTICALLY ACCEPTABLE SALT
- AN ASCORBIC ACID SALT OF SUNITINIB
- AN IMPROVED PROCESS FOR THE PREPARATION OF SUNITINIB AND ITS ACID ADDITION SALTS THEREOF
